NO885275L - Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav. - Google Patents

Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.

Info

Publication number
NO885275L
NO885275L NO88885275A NO885275A NO885275L NO 885275 L NO885275 L NO 885275L NO 88885275 A NO88885275 A NO 88885275A NO 885275 A NO885275 A NO 885275A NO 885275 L NO885275 L NO 885275L
Authority
NO
Norway
Prior art keywords
manufacturing
dnas coding
anticoagulant proteins
vascular anticoagulant
proteins
Prior art date
Application number
NO88885275A
Other languages
English (en)
Norwegian (no)
Other versions
NO885275D0 (no
Inventor
Rudolf Hauptmann
Ingrid Maurer-Fogy
Gerhard Bodo
Peter Swetly
Christian Stratowa
Edgar Falkner
Guenther Adolf
Christian Mar Reutelingsperger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873710309 external-priority patent/DE3710309A1/de
Priority claimed from DE19873710430 external-priority patent/DE3710430A1/de
Priority claimed from DE19873710364 external-priority patent/DE3710364A1/de
Priority claimed from DE19873737367 external-priority patent/DE3737367A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO885275D0 publication Critical patent/NO885275D0/no
Publication of NO885275L publication Critical patent/NO885275L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
NO88885275A 1987-03-28 1988-11-25 Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav. NO885275L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19873710309 DE3710309A1 (de) 1987-03-28 1987-03-28 Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE19873710430 DE3710430A1 (de) 1987-03-28 1987-03-28 Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE19873710364 DE3710364A1 (de) 1987-03-28 1987-03-28 Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE19873737367 DE3737367A1 (de) 1987-11-04 1987-11-04 Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
PCT/EP1988/000266 WO1988007576A2 (fr) 1987-03-28 1988-03-26 Proteines vasculaires anticoagulantes, leurs adn de codage, production et utilisation

Publications (2)

Publication Number Publication Date
NO885275D0 NO885275D0 (no) 1988-11-25
NO885275L true NO885275L (no) 1989-01-25

Family

ID=27433878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885275A NO885275L (no) 1987-03-28 1988-11-25 Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.

Country Status (17)

Country Link
US (1) US5837842A (sv)
EP (1) EP0293567B1 (sv)
JP (1) JPH01503515A (sv)
KR (1) KR890700666A (sv)
AT (1) ATE133707T1 (sv)
AU (1) AU625214B2 (sv)
DD (1) DD273285A5 (sv)
DE (1) DE3854950D1 (sv)
DK (1) DK175468B1 (sv)
FI (1) FI103892B1 (sv)
HU (1) HUT52544A (sv)
IE (2) IE74679B1 (sv)
IL (1) IL85878A (sv)
NO (1) NO885275L (sv)
NZ (1) NZ224057A (sv)
PT (1) PT87083B (sv)
WO (1) WO1988007576A2 (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2660514B2 (ja) * 1987-02-20 1997-10-08 興和株式会社 抗血液凝固作用を有するポリペプチド
ES2096556T3 (es) * 1988-02-26 1997-03-16 Biogen Inc Secuencias de adn, moleculas de adn recombinante y procedimientos para producir lipocortinas iii, iv, v y vi.
EP0339285A3 (en) * 1988-03-31 1989-11-29 RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) Recombinant endonexin ii
DE3910240A1 (de) * 1989-03-30 1990-10-04 Behringwerke Ag Pp4-delta, seine herstellung und verwendung
ATE89169T1 (de) * 1989-07-15 1993-05-15 Boehringer Ingelheim Int Antikoagulanz enthaltendes mittel.
DE3937607A1 (de) * 1989-11-11 1991-05-16 Boehringer Ingelheim Int Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
JP3135261B2 (ja) * 1989-12-27 2001-02-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗凝血剤の診断薬としての使用
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
JPH05508664A (ja) * 1991-05-09 1993-12-02 ボード・オブ・リージェンツ・オブ・ザ・ユニヴァーシティ・オブ・ワシントン リン脂質標的血栓溶解剤
PT672136E (pt) * 1992-07-08 2000-08-31 Innogenetics Nv Polipeptidos derivados da endonexina 2 tendo actividade receptora do virus da hepatite b e sua utilizacao em diagnostico e composicoes farmaceuticas
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
DE69527505D1 (de) * 1994-11-11 2002-08-29 Noboru Kaneko Monoklonaler antikörper gegen antiannexin-v, verfahren zu seiner herstellung und seiner verwendung
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
EP1839670A3 (en) * 2001-02-21 2009-11-11 Alavita Pharmaceuticals, Inc. Modified Annexin Proteins and their use against thrombosis
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US20050222030A1 (en) * 2001-02-21 2005-10-06 Anthony Allison Modified annexin proteins and methods for preventing thrombosis
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
EP1241269A3 (en) * 2001-03-16 2004-05-19 Ortho-Clinical Diagnostics, Inc. Method for detecting REG-like protein and nucleic acids coding therefor
DE60202240T2 (de) * 2001-05-21 2005-12-15 Fuji Photo Film Co., Ltd., Minami-Ashigara Vorrichtung zur Durchführung biochemischer Analysen und Verfahren zu ihrer Herstellung
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
FR2841557B1 (fr) * 2002-07-01 2005-12-09 Commissariat Energie Atomique Peptides ayant une affinite pour un phospholipide et utilisations
FR2841558B1 (fr) * 2002-07-01 2004-08-13 Commissariat Energie Atomique Peptides marques ayant une affinite pour un phospholipide et utilisations
EP2053409A1 (en) * 2003-11-20 2009-04-29 F. Hoffmann-La Roche Ag Specific markers for metabolic syndrome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
US5066788A (en) * 1984-09-21 1991-11-19 Boehringer Ingelheim International Gmbh Blood coagulation inhibiting proteins, processes for preparing them and their uses
NO164991C (no) * 1984-09-21 1990-12-05 Boehringer Ingelheim Int Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner.
CN86100721A (zh) * 1985-01-10 1987-02-11 比奥根公司 为人类脂皮质激素多肽编码的脱氧核糖核酸顺序，含有它的重组脱氧核糖核酸分子及制造该多肽的方法
WO1986006100A1 (en) * 1985-04-15 1986-10-23 Biotechnology Research Partners, Limited Human anti-inflammatory phospholipase inhibitor protein
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
WO1988005659A1 (en) * 1987-02-06 1988-08-11 Zymogenetics, Inc. Human proteins having anticoagulant and anti-inflammatory activity
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
US5179081A (en) * 1988-07-21 1993-01-12 Kowa Co., Ltd. Method of treatment using an anticoagulant polypeptide

Also Published As

Publication number Publication date
NO885275D0 (no) 1988-11-25
IE960853L (en) 1988-09-28
NZ224057A (en) 1991-04-26
FI103892B (sv) 1999-10-15
DK662288D0 (da) 1988-11-25
IL85878A0 (en) 1988-09-30
DK175468B1 (da) 2004-11-01
WO1988007576A3 (fr) 1989-01-26
ATE133707T1 (de) 1996-02-15
FI103892B1 (sv) 1999-10-15
AU1402788A (en) 1988-09-29
HUT52544A (en) 1990-07-28
WO1988007576A2 (fr) 1988-10-06
US5837842A (en) 1998-11-17
IE880928L (en) 1988-09-28
FI885504A0 (fi) 1988-11-28
JPH01503515A (ja) 1989-11-30
PT87083A (pt) 1988-04-01
KR890700666A (ko) 1989-11-26
EP0293567B1 (de) 1996-01-31
PT87083B (pt) 1992-07-31
IL85878A (en) 1993-07-08
IE74679B1 (en) 1997-07-30
FI885504A (fi) 1988-11-28
DE3854950D1 (de) 1996-03-14
AU625214B2 (en) 1992-07-02
DK662288A (da) 1989-01-25
EP0293567A1 (de) 1988-12-07
DD273285A5 (de) 1989-11-08

Similar Documents

Publication Publication Date Title
NO885275L (no) Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.
ES2142953T3 (es) Factor de crecimiento y diferenciacion de la familia del tgf-beta.
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
NO873753L (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
BR9609176A (pt) Composi-{es de agente biolÄgico
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
DE3882078D1 (de) Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung.
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
NO904024D0 (no) Heparin-bindende proteiner, dna som koder for dem, fremgangsmaater for fremstilling derav og terapeutisk preparater inneholdende dem.
ATE190630T1 (de) Angiotensin-ii typ-1 rezeptor und dessen herstellung
IT8919735A0 (it) Procedimento per la riduzione del cod da reflui industriali o urbani.
NO905496D0 (no) Biologisk forenelige, stoff-spesifikke reagenser til behandling av fysiologiske vaesker.
DE68918519D1 (de) DNA, welche für ein antikoagulierendes Polypeptid kodiert.
ZA897586B (en) Antidote
DK151788A (da) Hybridserpiner og dna, som koder derfor
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DE68919887D1 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
DE68917536D1 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
ATE193324T1 (de) Rekombinante herstellung von laktoperoxidase
ES555466A0 (es) Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.